Antioxidant supplement may boost IVF outcomes for older women

NCT ID NCT07685431

Recruiting now Disease control Sponsor: Kaohsiung Veterans General Hospital. Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study tests whether taking alpha-lipoic acid (ALA), a powerful antioxidant, for two months before IVF can improve egg quality and pregnancy rates in women aged 35-45 with infertility. Researchers will compare 30 women who take ALA with 30 who do not, measuring embryo quality, mitochondrial function in egg-supporting cells, and clinical pregnancy and live birth rates. The goal is to see if this simple supplement can counteract age-related fertility decline.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Alpha-lipoic acid (ALA), an antioxidant supplement
What this could lead to: If it works, this could point toward a simple supplement to improve egg quality and IVF success in older women.
What could go wrong: This is a small, early study with only 60 participants. The supplement may not improve pregnancy or live birth rates, and results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates